FHITness and cancer

Oncology Research

Volumn 10, Issue 7, 1998, Pages 341-345

  Druck, Teresa ^a   Berk, Lori ^a   Huebner, Kay ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Common fragile site FRA3B; FHIT gene; Homozygous deletions; Lung cancer; Tumor suppressor genes

Indexed keywords

ACID ANHYDRIDE HYDROLASE; FRAGILE HISTIDINE TRIAD PROTEIN; PROTEIN; TUMOR PROTEIN;

ALLELE; CELL CULTURE; GENETICS; HUMAN; LUNG TUMOR; NEOPLASM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; TUMOR SUPPRESSOR GENE;

ACID ANHYDRIDE HYDROLASES; ALLELES; GENES, TUMOR SUPPRESSOR; HUMANS; LUNG NEOPLASMS; NEOPLASM PROTEINS; NEOPLASMS; PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

EID: 0032241172     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Huebner, K.; Hadaczek, P.; Siprashvili, Z.; Druck, T.; Croce, C. M. The FHIT gene, a multiple tumor suppressor gene encompassing the carcinogen sensitive chromosome fragile site, FRA3B. Biochim. Biophys. Acta 1332:M65-M70; 1997.
2. Mao, L. Tumor suppressor genes: Does FHIT fit? J. Natl. Cancer Inst. 90:412-414; 1998.
3. Le Beau, M. M.; Drabkin, H.; Glover, T. W.; Gemmell, R.; Rassool, F. V.; McKeithan, T. W.; Smith, D. An FHIT tumor suppressor gene? Genes Chromosomes Cancer 21:281-289; 1998.
4. Ohta, M.; Inoue, H.; Cotticelli, M. G.; Kastury, K.; Baffa, R.; Palazzo, J.; Siprashvili, Z.; Mori, M.; McCue, P.; Druck, T.; Croce, C. M.; Huebner, K. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 84:587-597; 1996.
5. Le Beau, M. M. Chromosomal fragile sites and cancer-specific rearrangements. Blood 67:849-858; 1986.
6. Huebner, K.; Garrison, P. N.; Barnes, L. D.; Croce, C. M. The role of the FRA3B/FHIT locus in cancer. Annu. Rev. Genet. 32: 7-31; 1998.
7. Sozzi, G.; Tornielli, S.; Tagliabue, E.; Sard, L.; Pezzella, F.; Pastorino, U.; Minoletti, F.; Pilotti, S.; Ratcliffe, C.; Veronese, M. L.; Goldstraw, P.; Huebner, K.; Croce, C. M.; Pierotti, M. A. Absence of Fhit protein in primary lung tumors and cell lines with FHIT gene abnormalities. Cancer Res. 57:5207-5212; 1997.
8. Greenspan, D. L.; Connolly, D. C.; Wu, R.; Lei, R. Y.; Vogelstein, J. T. C.; Kim, Y.-T.; Mok, J. E.; Munoz, N.; Bosch, X.; Shah, K.; Cho, K. R. Loss of FHIT expression in cervical carcinoma cell lines and primary tumors. Cancer Res. 57:4692-4698; 1997.
9. Hadaczek, P.; Siprashvili, Z.; Markiewski, M.; Domagala, W.; Druck, T.; McCue, P. A.; Pekarsky, Y.; Ohta, M.; Huebner, K.; Lubinski, J. Absence or reduction of Fhit expression in most clear cell renal carcinomas. Cancer Res. 58:2946-2951; 1998.
10. Baffa, R.; Veronese, M. L.; Santoro, R.; Mandes, B.; Palazzo, J. P.; Rugge, M.; Santoro, E.; Croce, C. M.; Huebner, K. Loss of FHIT expression in gastric carcinoma. Cancer Res. 58:4708-4714; 1998.
11. Druck, T.; Kastury, K.; Hadaczek, P.; Podolski, J.; Toloczko, A.; Sikorski, A.; Ohta, M.; LaForgia, S.; Lasota, J.; McCue, P.; Lubinski, J.; Huebner, K. Loss of heterozygosity at the familial RCC t(3;8) locus in most clear cell renal carcinomas. Cancer Res. 55: 5348-5353; 1995.
12. Hadaczek, P.; Podolski, J.; Toloczko, A.; Kurzawski, G.; Sikorski, A.; Rabbitts, P.; Huebner, K.; Lubinski, J. Accumulation of losses at 3p common deletion sites is characteristic of clear cell renal cell carcinoma. Virchows Arch. 429:37-42; 1996.
13. Boldog, F.; Gemmill, R. M.; West, J.; Robinson, M.; Robinson, L.; Li, E.; Roche, J.; Todd, S.; Waggoner, B.; Lundstrom, R.; Jacobson, J.; Mullokandov, M. R.; Klinger, H.; Drabkin, H. A. Chromosome 3p14 homozygous deletions and sequence analysis of FRA3B. Hum. Mol. Genet. 6:193-203; 1997.
14. Wang, L.; Darling, J.; Zhng, J.-S.; Qian, C.-P.; Hartmann, L.; Conover, C.; Jenkins, R.; Smith, D. I. Frequent homozygous deletions in the FRA3B region in tumor cell lines still leave the FHIT exons intact. Oncogene 16:635-642; 1998.
15. Mao, L.; Lee, J. S.; Kurie, J. M.; Fan, Y. H.; Lippman, S. M.; Lee, J. J.; Ro, J. Y.; Broxson, A.; Yu, R.; Morice, R. C.; Kemp, B. L.; Khuri, F. R.; Walsh, G. L.; Hittelman, W. N.; Hong, W. K. Clonal genetic alterations in the lungs of current and former smokers. J. Natl. Cancer Inst. 89:857-862; 1997.
16. Wistuba, I. I.; Lam, S.; Behrens, C.; Virmani, A. K.; Fong, K. M.; LeRiche, J.; Samet, J. M.; Srivastava, S.; Minna, J. D.; Gazdar, A. F. Molecular damage in the bronchial epithelium of current and former smokers. J. Natl. Cancer Inst. 89:1366-1373; 1997.
17. Nelson, H. H.; Wiencke, J. K.; Gunn, L.; Wain, J. C.; Christiani, D. C.; Kelsey, K. T. Chromosome 3p14 alterations in lung cancer: Evidence that FHIT exon deletion is a target of tobacco carcinogens and asbestos. Cancer Res. 58:1804-1807; 1998.
18. Iliopoulos, O.; Kibel, A.; Gray, S.; Kaelin, J. W. G. Tumour suppression by the human von Hippel-Lindau gene product. Nat. Med. 1:822-826; 1995.
19. Pause, A.; Lee, S.; Lonergan, K. M.; Klausner, R. D. The von Hippel-Lindau tumor suppressor gene is required for cell cycle exit upon serum withdrawal. Proc. Natl. Acad. Sci. USA 95:993-998; 1998.
20. Druck, T.; Hadaczek, P.; Fu, T.-B.; Ohta, M.; Siprashvili, Z.; Baffa, R.; Negrini, M.; Kastury, K.; Veronese, M. L.; Rosen, D.; Rothstein, J.; McCue, P.; Cotticelli, M. G.; Inoue, H.; Croce, C. M.; Huebner, K. Structure and expression of the human FHIT gene in normal and tumor cells. Cancer Res. 57:504-512; 1997.
21. Inoue, H.; Ishii, H.; Alder, H.; Snyder, E.; Druck, T.; Huebner, K.; Croce, C. M. Sequence of the FRA3B common fragile region: Implications for the mechanism of FHIT deletion. Proc. Natl. Acad. Sci. USA 94:14584-14589; 1997.
22. Fong, K. M.; Biesterveld, E. J.; Virmani, A.; Wistuba, I.; Sekido, Y.; Bader, S. A.; Ahmadian, M.; Ong, S. T.; Rassool, F. V.; Zimmerman, P. V.; Ciaccone, G.; Gazdar, A. F.; Minna, J. A. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations. Cancer Res. 57:2256-2267; 1997.
23. Siprashvili, Z.; Sozzi, G.; Barnes, L. D.; McCue, P.; Robinson, A. K.; Eryomin, V.; Sard, L.; Tagliabue, E.; Greco, A.; Fusetti, L.; Schwartz, G.; Pierotti, M. A.; Croce, C. M.; Huebner, K. Replacement of Fhit in cancer cells suppresses tumorigenicity. Proc. Natl. Acad. Sci. USA 94:13771-13776; 1997.
24. Rassool, F. V.; Le Beau, M. M.; Neilly, M. E.; van Melle, E.; Espinosa, R.; McKeithan, T. W. Increased genetic instability of the common fragile site at 3p14 after integration of exogenous DNA. Am. J. Hum. Genet. 50:1243-1251; 1992.
25. Otterson, G. A.; Xiao, G.-H.; Geradts, J.; Jin, F.; Chen, W.; Niklinska, W.; Kaye, F. J.; Yeung, R. S. Protein expression and functional analysis of the FHIT gene in human tumor cells. J. Natl. Cancer Inst. 90:426-432; 1998.
26. Pekarsky, Y.; Druck, T.; Cotticelli, M. G.; Ohta, M.; Shou, J.; Mendrola, J.; Montgomery, J. C.; Buchberg, A. M.; Manenti, G.; Fong, L. Y. Y.; Croce, C. M.; Dragani, T.; Huebner, K. The murine Fhit locus: Isolation, characterization and expression in normal and tumor cells. Cancer Res. 58:3401-3408; 1998.
27. Glover, T. W.; Hoge, A.; Miller, D. E.; Ascara-Wilke, J. E.; Adam, A.; Dagenais, S. L.; Wilke, C. M.; Dierick, H. A.; Beer, D. G. The murine Fhit gene is highly similar to its human ortholog and maps to a common fragile site region. Cancer Res. 58:3409-3414; 1998.